Navigation Links
Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional
Date:2/22/2011

NEW BRUNSWICK, N.J. and LEIDEN, Netherlands, Feb. 22, 2011 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) and Crucell N.V. (NYSE Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) today announce that Johnson & Johnson has completed the tender offer for Crucell N.V. (Crucell) and has declared the offer unconditional.  As a result, Crucell will now operate as the center for vaccines within the Johnson & Johnson pharmaceuticals group.

Reference is made to the joint press release of Johnson & Johnson and Crucell dated 8 December 2010 announcing the recommended cash offer by Johnson & Johnson, through its indirect wholly-owned subsidiary JJC Acquisition Company B.V. (the Offeror), for all of the issued and outstanding ordinary shares (Ordinary Shares) in the capital of Crucell, including all Ordinary Shares represented by American depositary shares (ADSs), each ADS representing one Ordinary Share (Ordinary Shares and ADSs are referred to herein as the Shares and the holders of such Shares are referred to as the Shareholders) at an offer price of euro 24.75 per share (the Offer).

Johnson & Johnson will commence, through the Offeror, a subsequent offering period to allow Shareholders who have not yet accepted the Offer to tender their Shares, as further described below.  Johnson & Johnson encourages Shareholders who have not yet accepted the Offer to do so immediately.

Highlights

  • Johnson & Johnson declares the Offer unconditional
  • Share Acceptance Level is 95.24% of the issued and outstanding share capital of Crucell
  • Settlement of the Offer will take place on 25 February 2011
  • Remaining Shares can be tendered in a Subsequent Offering Period ending 8 March 2011

  • O
    '/>"/>

    SOURCE Johnson & Johnson
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Crucell Shareholders Adopt Offer Governance Resolutions and Johnson & Johnson Makes Announcement on U.S. Regulatory Matters
    2. Johnson & Johnson Recall of DePuy Hip Devices: Lewitt Hackman Files Suit
    3. Johnson & Johnson Receives Approval from European Commission
    4. Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer
    5. Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results
    6. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
    7. Reportlinker Adds Johnson & Johnson: PharmaVitae Profile
    8. Boston Scientific Announces Election of Dr. Kristina M. Johnson to its Board of Directors
    9. Johnson & Johnson Announces Executive Appointments: Alex Gorsky, Vice Chairman, Executive Committee Sheri McCoy, Vice Chairman, Executive Committee
    10. Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer
    11. Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Pharmaceutical Business
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/4/2015)... ROCHESTER, Minn. , March 4, 2015   ... reached an agreement to develop the next generation of ... "We are hoping that this technology will be ... obesity and diabetes," says James Levine, M.D., Ph.D. ... researcher. "They are accurate, inexpensive, and can be integrated ...
    (Date:3/4/2015)... PHILADELPHIA , March 4, 2015 ... be attending the 2015 Distribution Management Conference and ... This conference is HDMA,s largest supply chain education ... and third parties who keep the pharmaceutical distribution ... spotlight on regulatory and legislative issues important to ...
    (Date:3/4/2015)... March 4, 2015 Following the reintroduction ... Action Center (LAC) released a report today urging ... opioid and heroin epidemic through more effective use ... report, "The Case for Expanding Access to Medication-Assisted ... outlines the health, justice, and economic advantages of ...
    Breaking Medicine Technology:Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3Improved Medication-Assisted Treatment Policy Could Aid Epidemic of 20 Million Americans with Untreated Addiction 2
    ... , March 11 Watson Pharmaceuticals, Inc. ... Food and Drug Administration (FDA) approval of TRELSTAR® 22.5 ... formulation of TRELSTAR®, a proven, simple and effective palliative ... launch, TRELSTAR® 22.5 mg is the first and only ...
    ... SiteJabber.com , a leading consumer protection service which helps people avoid fraudulent websites and find good sites, and LegitScript.com ... websites and avoid fraudulent ones. , ... ... ...
    Cached Medicine Technology:FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 2FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 3FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 4FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 5FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 6FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 7FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 8SiteJabber & LegitScript Launch Partnership to Improve Transparency Around Online Pharmacies 2SiteJabber & LegitScript Launch Partnership to Improve Transparency Around Online Pharmacies 3
    (Date:3/4/2015)... (PRWEB) March 04, 2015 More than ... cardiovascular risks potentially associated with low testosterone treatments ( ... announced that it will now require manufacturers to warn ... risk for heart attacks and strokes. In a ... agency also stated that it was requiring testosterone manufacturers ...
    (Date:3/4/2015)... March 04, 2015 Alliance Healthcare Foundation ... wellness for those in need in San Diego and ... organizations through its Mission Support Grants program with awards ... organizations applied for AHF’s Mission Support Grants program. Grant ... board of trustees and program committee, as well as ...
    (Date:3/4/2015)... March 04, 2015 State officials have ... the School of Public Health at Georgia State University, ... were awarded by Georgia’s Division of Family and Children ... the DFCS Call Center. , The 1-800-CHILDREN Helpline ... providing information and referral services that promote the wellbeing ...
    (Date:3/4/2015)... (PRWEB) March 04, 2015 The New ... and lyrical music, will be performed by the award-winning ... Estates, CA, this March 6-22, 2015, on Fridays, Saturdays ... at Peninsula High School (27118 Silver Spur Road, ... hour before the program or may be purchased on-line ...
    (Date:3/4/2015)... 2015 The report covers spices ... marketing channels, industry development trend and proposals. The ... including spices definitions, applications and industry chain structure. ... are provided with a focus on history, developments, ... comparison between the international and Chinese situation is ...
    Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 3Health News:State Funds Child Abuse Helpline Housed At Georgia State 2Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 3
    ... Speaker Nancy Pelosi issued the following statement today ... Prevention and Tobacco Control Act, which gives the Food ... and marketing. , , "Today, President Obama ... making America healthier. This bipartisan legislation grants the FDA ...
    ... Park Targets Pittsburgh Children ... United Concordia Dental and the Pittsburgh Pirates organization began several years ago, ... community as Pennsylvanians and the nation struggle with the uncertainty of a ... will team up from 4 to 7 p.m. Monday June 29 at ...
    ... disorder marked in part by auditory hallucinations and paranoia, can ... when people are ready to stand on their own two ... scientists at UCLA think they are beginning to understand one ... its kind, the researchers used a novel form of brain ...
    ... MARINO, Calif., June 22 Epeius Biotechnologies ( ... with a dramatic demonstration of single-agent efficacy with its ... (accessible online as of June 16, 2009 in Molecular ... Gene Therapy, www.nature.com/mt/ ) documents the ...
    ... Washington, D.C.-based law firm of Schmidt & Clark, LLP ... the U.S. Food and Drug Administration where ... Inc. (NYSE: ABT ) failed to disclose multiple reports ... , , In an Associated Press story reported June 20, ...
    ... , HARBIN, China, June 22 ... Medical" or "the Company") (Nasdaq: CSKI ), ... People,s Republic of China ("PRC"), today announced that it,obtained ... proprietary Sumei,Slim Patch from Heilongjiang Provincial FDA, which will ...
    Cached Medicine News:Health News:Davis Vision, United Concordia Dental and The Pittsburgh Pirates Team Up to Provide Free Dental and Vision Screenings 2Health News:Davis Vision, United Concordia Dental and The Pittsburgh Pirates Team Up to Provide Free Dental and Vision Screenings 3Health News:Alterations in brain's white matter key to schizophrenia, UCLA study shows 2Health News:Clinical Studies Validate Cancer Gene Delivery Platform: Landmark Publication Confirms Rexin-G Effectively Targets Metastatic Cancers and Improves Patient Survival 2Health News:Schmidt & Clark, LLP: FDA Reports Show Abbott Labs Subsidiary Failed to Disclose Parasite Eye Infections Tied to Contact Lens Solution 2Health News:China Sky One Medical, Inc. Obtains Production License Renewal for Sumei Slim Patch 2Health News:China Sky One Medical, Inc. Obtains Production License Renewal for Sumei Slim Patch 3
    The MINI-TAG™ instrument systems are indicated for ulnar collateral ligament repair, scapholunate dissolution, flexor avulsions, and carpometa-carpal arthroplasty....
    Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
    Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
    Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
    Medicine Products: